Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...

Related Keywords

Ottawa ,Ontario ,Canada ,United States ,Westport ,Newfoundland ,Merck Sharpe Dohme ,Jonathan Nugent ,Lewish Bender ,Bristol Myers Squibb ,David Rosen ,Intensity Therapeutics Inc ,Company On Twitter Intensityinc ,Ottawa Hospital Research Institute ,National Cancer Institute ,Nasdaq ,Vaccine Branch ,Development Agreement ,Ontario Institute Of Cancer Research ,Intensity Therapeutics ,Chief Executive Officer ,Annual Global Investment Conference ,Merck Sharpe ,Ontario Institute ,Cancer Research ,Cooperative Research ,Looking Statements ,Relations Contact ,Nc ,